BJMO - volume 8, issue 4, september 2014
Tom Feys MBA, MSc, P. Specenier MD, PhD
Overview of Belgian reimbursement news
(BELG J MED ONCOL 2014;8(3):132)
Read moreBJMO - volume 8, issue 3, july 2014
L. Decoster MD, PhD, F. Cornélis MD, E. Joosens MD, S. Henry MD, P. Specenier MD, PhD, P. Clement MD, PhD, On behalf of the Thyroid Task Force of the BSMO
Thyroid cancers are rare diseases and include types that range from indolent localised differentiated carcinomas to fulminant and lethal anaplastic disease. Until recently, treatment options for advanced or metastatic radio-iodine refractory thyroid cancer were limited. Recently kinase inhibitors targeting angiogenesis and other pathways have shown promising activity.
(BELG J MED ONCOL 2014;8(3):81–6)
Read moreBJMO - volume 8, issue 2, may 2014
Tom Feys MBA, MSc, MBA , P. Specenier MD, PhD
Overview of Belgian reimbursement news.
(BELG J MED ONCOL 2014;8(2):59)
Read moreBJMO - volume 7, issue 4, september 2013
Tom Feys MBA, MSc, P. Specenier MD, PhD
(BELG J MED ONCOL 2013;7(4):133)
Read moreBJMO - volume 7, issue 3, july 2013
Tom Feys MBA, MSc, P. Specenier MD, PhD
Overview of Belgian reimbursement news.
(BELG J MED ONCOL 2013;7(3):101)
Read moreBJMO - volume 7, issue 2, may 2013
Tom Feys MBA, MSc, P. Specenier MD, PhD
Overview of Belgian reimbursement news.
(BELG J MED ONCOL 2013;7(2):68)
Read moreBJMO - volume 7, issue 1, february 2013
P. Specenier MD, PhD, Tom Feys MBA, MSc
(BELG J MED ONCOL 2013;7:34)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
